Earlier bone marrow transplantation (TCM) or hematopoietic stem cells (TSCC) in patients with chronic granulomatous disease was accompanied by a rather high failure rate. And often this was due to the unsatisfactory pre-transplant status of patients, in particular, with fungal infection, which, as is known, along with GVHD, occupies one of the leading places in the structure of post-transplant mortality.